Irwin's ItchIrwin has been quite restless on acquisition/merger/consolidation/takeover and has been saying it in his interviews ever since he joined.
Seems he didnt get the satisfaction and kicj of reckless buying at exhorbitant prices as experienced by many of his industry peers like Linton, Booth, Vic etc
We all know he had inclination on ACB as reported by media recently.
Prior to it, he was interested in Canntrust when they didnt have the licenses.
I am thinking if the additional $100 million has something to do with Canntrust. Canntrust was a strong leader in medical with lot of things going for them before the scandal. Its relationship with Apotex is also in public domain and the co holds $145 million in cash with no debt on its balance sheets.
Is Aphria one of the contenders with EY on canntrust?